Enrico Crea
Overview
Explore the profile of Enrico Crea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marconi G, Piciocchi A, Audisio E, Papayannidis C, Cerrano M, Minotti C, et al.
Blood Adv
. 2025 Mar;
PMID: 40048742
The standard induction treatment for acute myeloid leukemia (AML) has limited efficacy for patients with non-low-risk AML. We conducted a multicenter study phase 1b/2, GIMEMA AML1718, to investigate the safety...
2.
Piciocchi A, Cipriani M, Messina M, Marconi G, Arena V, Soddu S, et al.
EJHaem
. 2024 Apr;
5(2):353-359.
PMID: 38633115
Artificial Intelligence has the potential to reshape the landscape of clinical trials through innovative applications, with a notable advancement being the emergence of synthetic patient generation. This process involves simulating...
3.
Mannelli F, Guglielmelli P, Fazi P, Crea E, Piciocchi A, Vignetti M, et al.
Future Oncol
. 2023 Jan;
19(2):103-111.
PMID: 36651780
The management of patients with acute myeloid leukemia (blast phase) secondary to myeloproliferative neoplasms (MPNs) is extremely challenging and the outcome dismal, with a median overall survival of about 3-6 ...
4.
Mancino A, Crea E, Messina M, Ferrante M, Feraco M, Fazi P, et al.
Contemp Clin Trials Commun
. 2022 Sep;
29:100992.
PMID: 36105266
Regulation (EU) No 536/2014 (Clinical Trial Regulation, CTR) offers two precious tools to academic clinical research in Italy: - The right to transfer not-for-profit clinical trials data and results for...
5.
Marasco V, Piciocchi A, Candoni A, Pagano L, Guidetti A, Musto P, et al.
Br J Haematol
. 2022 Jul;
199(1):54-60.
PMID: 35906881
COVID-19 continues to be a relevant issue among patients with haematological malignancies (HM). Vaccines are frequently not effective in subjects on active treatment. In this multicentre retrospective study of Gruppo...
6.
Mannelli F, Gianfaldoni G, Guglielmelli P, Buccisano F, Caporale R, Chiarini M, et al.
Future Oncol
. 2021 Jul;
17(29):3787-3796.
PMID: 34254530
AMELIORATE is a Phase III, randomized trial aiming to personalize treatment intensity in -mutated acute myeloid leukemia. The current study provides an early appraisal of chemosensitivity based on peripheral blasts...
7.
Rigolin G, Cavazzini F, Piciocchi A, Arena V, Visentin A, Reda G, et al.
Hematol Oncol
. 2021 Mar;
39(3):326-335.
PMID: 33739461
Because the efficacy of new drugs reported in trials may not translate into similar results when used in the real-life, we analyzed the efficacy of idelalisib and rituximab (IR) in...
8.
Lucchini E, Palandri F, Volpetti S, Vianelli N, Auteri G, Rossi E, et al.
Br J Haematol
. 2021 Feb;
193(2):386-396.
PMID: 33618438
Up to 30% immune thrombocytopenia (ITP) patients achieve a sustained remission off-treatment (SROT) after discontinuation of thrombopoietin receptor agonists (TPO-RAs). Factors predictive of response are lacking. Patients aged ≥18 years...
9.
Chiaretti S, Messina M, Della Starza I, Piciocchi A, Cafforio L, Cavalli M, et al.
Haematologica
. 2020 May;
106(6):1559-1568.
PMID: 32467145
Early recognition of Ph-like acute lymphoblastic leukemia cases could impact on the management and outcome of this subset of B-lineage ALL. To assess the prognostic value of the Ph-like status...
10.
Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, et al.
Am J Hematol
. 2016 Feb;
91(5):E293-5.
PMID: 26910388
In patients with immune thrombocytopenia (ITP) refractory to corticosteroids and intravenous immunoglobulins (IVIG), splenectomy may result at higher risk of peri-operative complications and, for this reason, potentially contraindicated. The thrombopoietin...